BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

  Copies of these documents may be obtained online at www.sedar.com, or the Company’s website, www.resverlogix.com, or by emailing ir@resverlogix.com

  December 15, 2017

   · 

  1 min read
• Business

  Mesoblast Grants Tigenix an Exclusive Global Patent License to Use Adipose-Derived Mesenchymal Stem Cells in the Local Treatment of Fistulae

  The agreement includes the right for TiGenix to grant sub-licenses to affiliates and third parties, including TiGenix’s current development and commercialization partner ex-United States.

  December 15, 2017

   · 

  8 min read
• Business

  BioDelivery Sciences Reacquires ONSOLIS From Collegium Pharmaceutical

  BDSI and Collegium entered into a license and development agreement for U.S. rights to ONSOLIS in May 2016.

  December 15, 2017

   · 

  4 min read
• Pharm Country

  Pfizer Inc. Announces Expiration and Results of Its Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 and Related Tender Offer

  Pfizer announced the expiration and results of its previously announced offers to exchange and to repurchase any and all of its outstanding £1,500,000,000 6.500 per cent.

  December 15, 2017

   · 

  11 min read
• Business

  Hemovent Appoints Professor Alain Combes, MD, PhD, to Its Scientific Advisory Board

  Hemovent announced today it has established a Scientific Advisory Board with the appointment of Professor Alain Combes, MD, PhD.

  December 15, 2017

   · 

  2 min read
• Business

  Spero Therapeutics Announces 3Q17 Operating Results and Pipeline Update

  The Company reported a net loss of $(12.1) million, or basic and diluted net loss per common share of $(36.02), for the third quarter of 2017.

  December 15, 2017

   · 

  10 min read
• Genetown

  Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

  Acer intends to use the net proceeds from this offering to fund its research and development efforts, to seek regulatory approval for EDSIVO and more.

  December 15, 2017

   · 

  4 min read
• Elekta Collaborates With Palabra to Offer the Industry’s Only Voice-Endable EHR

  The integrated system has been installed in sites in North America and Australia.

  December 15, 2017

   · 

  2 min read
• FDA

  Aclaris Nabs FDA Approval for ESKATA Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)

  SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern.

  December 15, 2017

   · 

  7 min read
• Business

  NOTICE TO THE MARKET: Grupo Biotoscana Announces Hiring of Executive VP of R&D

  Grupo Biotoscana announces to its shareholders and the market in general that has hired Ivan French as Executive VP of Research and Development.

  December 15, 2017

   · 

  2 min read